A more recent study shows that the chemotherapeutic drug cyclophosphamide induces the expression of CXCL3 by tumor cells, leading to intratumoral migration of CD4+ T cells expressing cytotoxic molecules, which are able to eradicate the tumor through specific tumor immunity [104]. This evidence concerns the gene CD4 and neoplasm.